Skip to main content
Top
Published in: Virology Journal 1/2021

Open Access 01-12-2021 | Human Papillomavirus | Research

Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study

Authors: Jaehyun Seong, Sangmi Ryou, JeongGyu Lee, Myeongsu Yoo, Sooyoung Hur, Byeong-Sun Choi, The Korea HPV Cohort Study

Published in: Virology Journal | Issue 1/2021

Login to get access

Abstract

Background

Persistent human papillomavirus (HPV) infection is a key factor for the development and progression of cervical cancer. We sought to identify the type-specific HPV prevalence by cervical cytology and assess disease progression risk based on high-risk persistent HPV infection in South Korea.

Methods

To investigate the HPV prevalence by Pap results, we searched seven literature databases without any language or date restrictions until July 17, 2019. To estimate the risk of disease progression by HPV type, we used the Korea HPV Cohort study data. The search included the terms “HPV” and “Genotype” and “Korea.” Studies on Korean women, type-specific HPV distribution by cytological findings, and detailed methodological description of the detection assay were included. We assessed the risk of disease progression according to the high-risk HPV type related to the nonavalent vaccine and associated persistent infections in 686 HPV-positive women with atypical squamous cells of uncertain significance or low-grade squamous intraepithelial lesions from the Korea HPV Cohort Study. Type-specific HPV prevalence was the proportion of women positive for a specific HPV genotype among all HPV-positive women tested for that genotype in the systematic review.

Results

We included 23 studies in our review. HPV-16 was the most prevalent, followed by HPV-58, -53, -70, -18, and -68. In women with high-grade squamous intraepithelial lesions, including cancer, HPV-16, -18, and -58 were the most prevalent. In the longitudinal cohort study, the adjusted hazard ratio of disease progression from atypical squamous cells of uncertain significance to high-grade squamous intraepithelial lesions was significantly higher among those with persistent HPV-58 (increase in risk: 3.54–5.84) and HPV-16 (2.64–5.04) infections.

Conclusions

While HPV-16 was the most prevalent, persistent infections of HPV-16/58 increased the risk of disease progression to high-grade squamous intraepithelial lesions. Therefore, persistent infections of HPV-16 and -58 are critical risk factors for cervical disease progression in Korea. Our results suggest that equal attention should be paid to HPV-58 and -16 infections and provide important evidence to assist in planning the National Immunization Program in Korea.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–70.CrossRef de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–70.CrossRef
2.
go back to reference Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.CrossRef Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518–27.CrossRef
3.
go back to reference Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191-203.CrossRef Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8:e191-203.CrossRef
4.
go back to reference Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2018, Ministry of Health and Welfare, 2020. Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2018, Ministry of Health and Welfare, 2020.
5.
go back to reference Vintermyr OK, Andersland MS, Bjørge T, Skar R, Iversen OE, Nygård M, Haugland HK. Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears. Int J Cancer. 2018;143:851–60.CrossRef Vintermyr OK, Andersland MS, Bjørge T, Skar R, Iversen OE, Nygård M, Haugland HK. Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears. Int J Cancer. 2018;143:851–60.CrossRef
6.
go back to reference Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131:2201–21.CrossRef Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131:2201–21.CrossRef
8.
go back to reference Kim YT, Serrano B, Lee JK, Lee H, Lee SW, Freeman C, et al. Burden of human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea. Papillomavirus Res. 2019;7:26–42.CrossRef Kim YT, Serrano B, Lee JK, Lee H, Lee SW, Freeman C, et al. Burden of human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea. Papillomavirus Res. 2019;7:26–42.CrossRef
9.
go back to reference Vonsky M, Shabaeva M, Runov A, Lebedeva N, Chowdhury S, Palefsky JM, Isaguliants M. Carcinogenesis associated with human papillomavirus infection. Mechanisms and potential for immunotherapy Biochemistry (Mosc). 2019;84:782–99.CrossRef Vonsky M, Shabaeva M, Runov A, Lebedeva N, Chowdhury S, Palefsky JM, Isaguliants M. Carcinogenesis associated with human papillomavirus infection. Mechanisms and potential for immunotherapy Biochemistry (Mosc). 2019;84:782–99.CrossRef
10.
go back to reference Araldi RP, Sant’Ana TA, Módolo DG, de Melo TC, Spadacci-Morena DD, de Cassia Stocco R, et al. The human papillomavirus (HPV)-related cancer biology: an overview. Biomed Pharmacother 2018;106:1537–56. Araldi RP, Sant’Ana TA, Módolo DG, de Melo TC, Spadacci-Morena DD, de Cassia Stocco R, et al. The human papillomavirus (HPV)-related cancer biology: an overview. Biomed Pharmacother 2018;106:1537–56.
11.
go back to reference So KA, Kim MJ, Lee KH, Lee IH, Kim MK, Lee YK, et al. The impact of high-risk HPV genotypes other than HPV 16/18 on the natural course of abnormal cervical cytology: a Korean HPV cohort study. Cancer Res Treat. 2016;48:1313–20.CrossRef So KA, Kim MJ, Lee KH, Lee IH, Kim MK, Lee YK, et al. The impact of high-risk HPV genotypes other than HPV 16/18 on the natural course of abnormal cervical cytology: a Korean HPV cohort study. Cancer Res Treat. 2016;48:1313–20.CrossRef
12.
go back to reference Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016. J Gynecol Oncol 2018;29:e14. Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016. J Gynecol Oncol 2018;29:e14.
13.
go back to reference So KA, Kim SA, Lee YK, Lee IH, Lee KH, Rhee JE, et al. Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: the Korean HPV cohort. Obstet Gynecol Sci. 2018;61:662–8.CrossRef So KA, Kim SA, Lee YK, Lee IH, Lee KH, Rhee JE, et al. Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: the Korean HPV cohort. Obstet Gynecol Sci. 2018;61:662–8.CrossRef
14.
go back to reference Pretorius RG, Peterson P, Azizi F, Burchette RJ. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol. 2006;195:1260–5.CrossRef Pretorius RG, Peterson P, Azizi F, Burchette RJ. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol. 2006;195:1260–5.CrossRef
15.
go back to reference Oh JK, Jeong BY, Yun EH, Lim MK. Awareness of and attitudes toward human papillomavirus vaccination among adults in Korea: 9-year changes in nationwide surveys. Cancer Res Treat. 2018;50:436–44.CrossRef Oh JK, Jeong BY, Yun EH, Lim MK. Awareness of and attitudes toward human papillomavirus vaccination among adults in Korea: 9-year changes in nationwide surveys. Cancer Res Treat. 2018;50:436–44.CrossRef
16.
go back to reference Lee KE. Issues on current HPV vaccination in Korea and proposal statement. Korean J Women Health Nurs. 2019;25:359–64.CrossRef Lee KE. Issues on current HPV vaccination in Korea and proposal statement. Korean J Women Health Nurs. 2019;25:359–64.CrossRef
17.
go back to reference Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS ONE 2015;10:e0122488. Ogembo RK, Gona PN, Seymour AJ, Park HS, Bain PA, Maranda L, Ogembo JG. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PLoS ONE 2015;10:e0122488.
18.
go back to reference Lee WC, Lee SY, Koo YJ, Kim TJ, Hur SY, Hong SR, et al. Establishment of a Korea HPV cohort study. J Gynecol Oncol. 2013;24:59–65.CrossRef Lee WC, Lee SY, Koo YJ, Kim TJ, Hur SY, Hong SR, et al. Establishment of a Korea HPV cohort study. J Gynecol Oncol. 2013;24:59–65.CrossRef
19.
go back to reference Park HK, Kang YM, Park JM, Choi YJ, Kim YN, Jeong DH, Kim KT. Prevalence and genotyping of HPV in different grades of cervical intraepithelial neoplasia and cervical cancer. Korean J Gynecol Oncol Colposc. 2003;14:12332. Park HK, Kang YM, Park JM, Choi YJ, Kim YN, Jeong DH, Kim KT. Prevalence and genotyping of HPV in different grades of cervical intraepithelial neoplasia and cervical cancer. Korean J Gynecol Oncol Colposc. 2003;14:12332.
20.
go back to reference Cho EJ, Do JH, Kim YS, Bae S, Ahn WS. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with hybrid capture II, DNA chip and sequencing methods. J Med Microbiol. 2011;60:162–71.CrossRef Cho EJ, Do JH, Kim YS, Bae S, Ahn WS. Evaluation of a liquid bead array system for high-risk human papillomavirus detection and genotyping in comparison with hybrid capture II, DNA chip and sequencing methods. J Med Microbiol. 2011;60:162–71.CrossRef
21.
go back to reference Lee D, Kim S, Park S, Jin H, Kim TU, Park KH, Lee H. Human papillomavirus prevalence in Gangwon province using reverse blot hybridization assay. Korean J Pathol. 2011;45:34853. Lee D, Kim S, Park S, Jin H, Kim TU, Park KH, Lee H. Human papillomavirus prevalence in Gangwon province using reverse blot hybridization assay. Korean J Pathol. 2011;45:34853.
22.
go back to reference Kyeong HE, Ha SY, Chung DH, Kim NR, Park S, Cho HY. The usefulness of the HPV DNA microchip test for women with ASC-US. Korean J Pathol. 2009;43:2549.CrossRef Kyeong HE, Ha SY, Chung DH, Kim NR, Park S, Cho HY. The usefulness of the HPV DNA microchip test for women with ASC-US. Korean J Pathol. 2009;43:2549.CrossRef
23.
go back to reference Hwang HS, Park M, Lee SY, Kwon KH, Pang MG. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol Biomarkers Prev. 2004;13:2153–6.PubMed Hwang HS, Park M, Lee SY, Kwon KH, Pang MG. Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip. Cancer Epidemiol Biomarkers Prev. 2004;13:2153–6.PubMed
24.
go back to reference Kwon JE, Kim YS, Kim SJ, Na YJ, Kim IH, Lee SY, et al. Establishment of general primers and oligo-DNA chip for the detection and typing of human papillomavirus. Korean J Gynecol Oncol Colposc. 2004;15:2319. Kwon JE, Kim YS, Kim SJ, Na YJ, Kim IH, Lee SY, et al. Establishment of general primers and oligo-DNA chip for the detection and typing of human papillomavirus. Korean J Gynecol Oncol Colposc. 2004;15:2319.
25.
go back to reference Kahng J, Lee HJ. Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J Lab Med. 2008;28:70–8.PubMed Kahng J, Lee HJ. Clinical efficacy of HPV DNA chip test in the era of HPV vaccination: 1,211 cases, a single institution study. Korean J Lab Med. 2008;28:70–8.PubMed
26.
go back to reference Kim MJ, Kim JJ, Kim S. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: data from the health check-ups of 7,014 Korean women. Obstet Gynecol Sci. 2013;56:110–20.CrossRef Kim MJ, Kim JJ, Kim S. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: data from the health check-ups of 7,014 Korean women. Obstet Gynecol Sci. 2013;56:110–20.CrossRef
27.
go back to reference Lee KO, Jeong SJ, Park MY, Seong HS, Shin ES, Choi KH, et al. Prevalence of human papillomavirus genotypes in routine Pap smear of 2,562 Korean women determined by PCR-DNA sequencing. J Bacteriol Virol. 2009;39:337–44.CrossRef Lee KO, Jeong SJ, Park MY, Seong HS, Shin ES, Choi KH, et al. Prevalence of human papillomavirus genotypes in routine Pap smear of 2,562 Korean women determined by PCR-DNA sequencing. J Bacteriol Virol. 2009;39:337–44.CrossRef
28.
go back to reference Lee B, Suh DH, Kim K, Kim YB. Utility of human papillomavirus genotyping for triage of patients with atypical squamous cells of undetermined significance by cervical cytology. Anticancer Res. 2015;35:4197–202.PubMed Lee B, Suh DH, Kim K, Kim YB. Utility of human papillomavirus genotyping for triage of patients with atypical squamous cells of undetermined significance by cervical cytology. Anticancer Res. 2015;35:4197–202.PubMed
29.
go back to reference Park MS, Cho HW, Kim JG, Bae NY, Oh DS, Park HH. Genotype analysis of human papilloma virus infection in accordance with cytological diagnoses. Korean J Clin Lab Sci. 2015;47:39–45.CrossRef Park MS, Cho HW, Kim JG, Bae NY, Oh DS, Park HH. Genotype analysis of human papilloma virus infection in accordance with cytological diagnoses. Korean J Clin Lab Sci. 2015;47:39–45.CrossRef
30.
go back to reference Nah EH, Cho S, Kim S, Cho HI. Human papillomavirus genotype distribution among 18,815 women in 13 Korean cities and relationship with cervical cytology findings. Ann Lab Med. 2017;37:426–33.CrossRef Nah EH, Cho S, Kim S, Cho HI. Human papillomavirus genotype distribution among 18,815 women in 13 Korean cities and relationship with cervical cytology findings. Ann Lab Med. 2017;37:426–33.CrossRef
31.
go back to reference Oh JK, Alemany L, Suh JI, Rha SH, Muñoz N, Bosch FX, et al. Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958–2004. Asian Pac J Cancer Prev. 2010;11:993–1000.PubMed Oh JK, Alemany L, Suh JI, Rha SH, Muñoz N, Bosch FX, et al. Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958–2004. Asian Pac J Cancer Prev. 2010;11:993–1000.PubMed
32.
go back to reference Park TC, Kim CJ, Koh YM, Lee KH, Yoon JH, Kim JH, et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol. 2004;23:119–25.CrossRef Park TC, Kim CJ, Koh YM, Lee KH, Yoon JH, Kim JH, et al. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia. DNA Cell Biol. 2004;23:119–25.CrossRef
33.
go back to reference Seo HH, Kim YJ, Jeong MS, Hong SR, Lee IH, So KA, et al. Combined SYBR Green real-time polymerase chain reaction and microarray method for the simultaneous determination of human papillomavirus loads and genotypes. Obstet Gynecol Sci. 2016;59:489–97.CrossRef Seo HH, Kim YJ, Jeong MS, Hong SR, Lee IH, So KA, et al. Combined SYBR Green real-time polymerase chain reaction and microarray method for the simultaneous determination of human papillomavirus loads and genotypes. Obstet Gynecol Sci. 2016;59:489–97.CrossRef
34.
go back to reference Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan. South Korea Int J Cancer. 2003;103:413–21.CrossRef Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, et al. Prevalence of human papillomavirus infection in women in Busan. South Korea Int J Cancer. 2003;103:413–21.CrossRef
35.
go back to reference Chung S, Shin S, Yoon JH, Roh EY, Seoung SJ, Kim GP, Kim E. Prevalence and genotype of human papillomavirus infection and risk of cervical dysplasia among asymptomatic Korean women. Ann Clin Microbiol. 2013;16:87–91.CrossRef Chung S, Shin S, Yoon JH, Roh EY, Seoung SJ, Kim GP, Kim E. Prevalence and genotype of human papillomavirus infection and risk of cervical dysplasia among asymptomatic Korean women. Ann Clin Microbiol. 2013;16:87–91.CrossRef
36.
go back to reference Hong SR, Kim IS, Kim DW, Kim MJ, Kim AR, Kim YO, et al. Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: a multicenter study. Korean J Pathol. 2009;43:342–50.CrossRef Hong SR, Kim IS, Kim DW, Kim MJ, Kim AR, Kim YO, et al. Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: a multicenter study. Korean J Pathol. 2009;43:342–50.CrossRef
37.
go back to reference Kim S, Lee D, Kim Y, Kim GH, Park SJ, Choi YI, et al. Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer. J Exp Biomed Sci. 2012;18:123–30. Kim S, Lee D, Kim Y, Kim GH, Park SJ, Choi YI, et al. Clinical evaluation of human papillomavirus DNA genotyping assay to diagnose women cervical cancer. J Exp Biomed Sci. 2012;18:123–30.
38.
go back to reference Tong SY, Lee YS, Park JS, Namkoong SE. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix. Int J Gynecol Cancer. 2007;17:1307–13.CrossRef Tong SY, Lee YS, Park JS, Namkoong SE. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix. Int J Gynecol Cancer. 2007;17:1307–13.CrossRef
39.
go back to reference Lee WS, Park JT, Lee GH, Seong SJ, Jung SE, Lee NW, Lee KW. The efficacy of HPV DNA chip test in the atypical squamous cell of undetermined significance. Korean J Gynecol Oncol. 2005;16:323–32.CrossRef Lee WS, Park JT, Lee GH, Seong SJ, Jung SE, Lee NW, Lee KW. The efficacy of HPV DNA chip test in the atypical squamous cell of undetermined significance. Korean J Gynecol Oncol. 2005;16:323–32.CrossRef
40.
go back to reference An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003;97:1672–80.CrossRef An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer. 2003;97:1672–80.CrossRef
41.
go back to reference Wu J, Ding C, Liu X, Zhou Y, Tian G, Lan L, et al. Worldwide burden of genital human papillomavirus infection in female sex workers: a systematic review and meta-analysis. Int J Epidemiol. 2021;50:527–37.CrossRef Wu J, Ding C, Liu X, Zhou Y, Tian G, Lan L, et al. Worldwide burden of genital human papillomavirus infection in female sex workers: a systematic review and meta-analysis. Int J Epidemiol. 2021;50:527–37.CrossRef
42.
go back to reference Li M, Du X, Lu M, Zhang W, Sun Z, Li L, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing. China J Med Virol. 2019;91:473–81.CrossRef Li M, Du X, Lu M, Zhang W, Sun Z, Li L, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing. China J Med Virol. 2019;91:473–81.CrossRef
43.
go back to reference Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS ONE 2013;8:e79260. Jaisamrarn U, Castellsagué X, Garland SM, Naud P, Palmroth J, Del Rosario-Raymundo MR, et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS ONE 2013;8:e79260.
44.
go back to reference Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365–71.CrossRef Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87:1365–71.CrossRef
45.
go back to reference Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183:8–15.CrossRef Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183:8–15.CrossRef
46.
go back to reference Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol. 2003;71:265–73.CrossRef Kay P, Soeters R, Nevin J, Denny L, Dehaeck CM, Williamson AL. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol. 2003;71:265–73.CrossRef
47.
go back to reference Seong J, Ryou S, Yoo M, Lee J, Kim K, Jee Y, et al. Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study. J Gynecol Oncol 2020;31:e4. Seong J, Ryou S, Yoo M, Lee J, Kim K, Jee Y, et al. Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study. J Gynecol Oncol 2020;31:e4.
Metadata
Title
Enhanced disease progression due to persistent HPV-16/58 infections in Korean women: a systematic review and the Korea HPV cohort study
Authors
Jaehyun Seong
Sangmi Ryou
JeongGyu Lee
Myeongsu Yoo
Sooyoung Hur
Byeong-Sun Choi
The Korea HPV Cohort Study
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2021
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-021-01657-2

Other articles of this Issue 1/2021

Virology Journal 1/2021 Go to the issue